Seborrheic Dermatitis Treatment Market
Seborrheic Dermatitis is a type of eczema that appears on oil-producing glands like the scalp, nose and upper back. Seborrheic Dermatitis can be caused due to hormonal changes or illness, cold, dry weather, stress, harsh detergents, chemicals and soaps. It is characterized by itchy reddish or pink patches of skin, accompanied by greasy flakes or scales. Seborrheic Dermatitis is a common dermatological disorder in the United States and worldwide.
Seborrheic Dermatitis is more prevalent in immune-compromised patients such as HIV patients, patients with lymphoma and organ transplant recipients.
Dandruff is considered to be a mild form of Seborrheic dermatitis and comparing with Seborrheic Dermatitis, dandruff is much more common, and affects approximately 50% of the general adult population worldwide. According to National Center for Biotechnology Information, In a study in the U.S. and China, dandruff prevalence was 81–95% in African Americans, 66–82% in Caucasians, and 30–42% in Chinese.
In mild cases, a medicated shampoo or a topical antifungal cream or (such as selenium sulfide, ketoconazole, coal tar) may be enough to control symptoms whereas in severe cases, we may require a prescription for a mild corticosteroid medication to calm the inflammation. Recent improvements in the eczema treatment have increased the quality of life of many patients but still a large affected population of about 66.3 million patients are left untapped.
Seborrheic Dermatitis Treatment Market: Drivers and Restraints
Advancements in Seborrheic Dermatitis products and treatment methods have led to the integration of innovative solutions in Seborrheic Dermatitis Furthermore, rising awareness regarding personal care products, and increasing adoption of e-Commerce marketing techniques by manufacturers of Seborrheic Dermatitis products is expected to create a favourable environment for the growth of the Seborrheic Dermatitis market over the forecast period. better patient-physician relationships leading to increasing demand for treatments pertaining to face and skin related problems is also propelled the growth of the Seborrheic Dermatitis Treatment market. However, stringent regulations for product approvals and generic competition are the factors that can hinder the market growth of Seborrheic Dermatitis Treatment globally.
Seborrheic Dermatitis Treatment Market: Segmentation
- Antifungal products
- Corticosteroid lotions
- Prescription-strength medicated shampoos
- Sulfur products
Route of Administration
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
Market Research Methodology – Perfected through Years of Diligence
A key factor for our unrivalled market research accuracy is our expert- and data-driven research methodologies. We combine an eclectic mix of experience, analytics, machine learning, and data science to develop research methodologies that result in a multi-dimensional, yet realistic analysis of a market.
Seborrheic Dermatitis Treatment Market: Overview
Based upon the most recent evidence, the aetiology of dandruff and Seborrheic dermatitis appears to be dependent upon three factors: microfloral metabolism, sebaceous gland secretions, and individual susceptibility. Traditionally, non-scalp seborrheic dermatitis has been treated with either topical or oral steroids. However, renewed interest in the role of Malassezia yeasts and the known side effects of topical steroids have made antifungal medications an increasingly popular choice which in turn expected to have a meteoric growth of the Seborrheic Dermatitis Treatment market over a forecast period.
Seborrheic Dermatitis Treatment Market: Region-wise Outlook
A geographic condition regarding for Seborrheic Dermatitis Treatment market has been segmented into five broad regions: North America, Latin America, Europe, Asia-Pacific including Japan, and the Middle East & Africa. North America leads the market for Seborrheic Dermatitis Treatment reasons being lifestyle changes, new product innovations, and early treatment adoption. Europe is the second leading market for Seborrheic Dermatitis Treatment due to development activities and a large research base. The Asia Pacific market is also expected to grow at a higher rate owing to changing lifestyle, a large target patient pool, rapid population growth, adoption of western lifestyle, and growth in research and development. These factor are likely to drive the market growth of the Seborrheic Dermatitis Treatment market during the forecast period globally.
Seborrheic Dermatitis Treatment Market: Key Market Participants
Some of the major key players of Seborrheic Dermatitis Treatment market constitute Sonoma Pharmaceuticals, Inc., Merck & Co., Inc., West-Ward Pharmaceuticals Corp.,
Allen & Hanburys A Glaxo Canada Ltd. Co., Valeant Pharmaceuticals North America
The report covers an exhaustive analysis on
- Market Segments
- Market Dynamics
- Historical Actual Market Size, 2012 – 2014
- Market Size & Forecast 2015 to 2024
- Supply & Demand Value Chain
- Market Current Trends/Issues/Challenges
- Competition & Companies involved
- Value Chain
- Aircraft Refurbishing Market Drivers and Restraints
Regional analysis for the Market includes
- North America
- Latin America
- Asia Pacific & Japan
- The Middle East and Africa
- Shifting Industry dynamics
- In-depth market segmentation
- Historical, current and projected industry size Recent industry trends
- Key Competition landscape
- Strategies of key players and product offerings
- Potential and niche segments/regions exhibiting promising growth
- A neutral perspective towards market performance
Seborrheic Dermatitis Treatment Market
- Update to San Jose Hair Transplant Information
- Clinical study aims to help restore hair
- Global Hair Loss Men and Women Market Report
- Hans Wiemann Hosts National Women’s Hair Loss Seminar In St Louis, MO
- Global OTC Hair Loss Treatment
- The Canadian Institute of Hair and Scalp Specialists Weighs in on Man Left Scarred After Hair Transplant
- Hair Products Cause Hair Loss
- Robotic Hair Transplant System
- Alopecia Global Clinical Trials Review, H1, 2015
- HydraFacial Keravive to promote scalp health